Skip to content

ADVIA Centaur® aTPO 10630886Recalls & reported problems

Siemens Healthcare Diagnostics Inc. · TPO Ab - CENTAUR - RGT - 100 tests · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
0
Deaths reported
0
Injuries reported
0
Recalls naming it
1

Summary

No MAUDE adverse event reports in our data reference this device identifier directly.

1 FDA recall record name this device's identifier, 1 still open.

1 other recall cover devices cleared under the same FDA submission (K003291); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

  1. Aug 21, 2024Class IIOpen, Classified

    Positive bias in patient results at and below the cut-off of 60 U/mL with the lots listed in the table below when compared to alternate lots on the Atellica IM analyzer.

    Z-3304-2024 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K003291. One submission often covers many models, so check the product and lot details in each record.

  • Z-3305-2024 · Aug 21, 2024 · Open, Classified
    Atellica IM aTPO Assay, Material Number 10995466 (100 Test) and 10995467 (500 Test)

Other SYSTEM, TEST, THYROID AUTOANTIBODY devices

All SYSTEM, TEST, THYROID AUTOANTIBODY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page